TNDM

Tandem Diabetes Care, Inc.

42.88 USD
+0.04 (+0.09%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Tandem Diabetes Care, Inc. stock is down -13.69% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 54.55% of the previous 10 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 9 CALLs, 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
31 May 18:44 21 Jun, 2024 55.00 CALL 149 1708
05 Jun 16:51 21 Jun, 2024 70.00 CALL 297 1097
05 Jun 17:30 21 Jun, 2024 75.00 CALL 466 1298
05 Jun 17:46 21 Jun, 2024 75.00 CALL 204 1298
06 Jun 14:34 19 Jul, 2024 50.00 CALL 45 321
06 Jun 16:41 21 Jun, 2024 52.50 CALL 999 2011
10 Jun 16:08 19 Jul, 2024 42.50 PUT 300 35
10 Jun 16:22 19 Jul, 2024 52.50 CALL 345 1189
13 Jun 19:53 21 Jun, 2024 42.50 CALL 92 72
14 Jun 13:30 15 Nov, 2024 60.00 CALL 90 272

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system. It also offers t:connect, a web-based data management application, continuous glucose monitoring, and supported blood glucose meters.

  • Oppenheimer
    Mon Jun 10, 07:20
    buy
    confirm
  • Redburn Atlantic
    Thu May 30, 06:11
    buy
    initial